1. A Phase I Dose Escalation Study Demonstrates Quercetin Safety and Explores Potential for Bioflavonoid Antivirals in Patients with Chronic Hepatitis C. (1st December 2015) Authors: Lu, Nu T.; Crespi, Catherine M.; Liu, Natalie M.; Vu, James Q.; Ahmadieh, Yasaman; Wu, Sheng; Lin, Sherry; McClune, Amy; Durazo, Francisco; Saab, Sammy; Han, Steven; Neiman, David C.; Beaven, Simon; French, Samuel W. Journal: Phytotherapy research Issue: Volume 30:Number 1(2016) Page Start: 160 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Sofosbuvir and simeprevir is effective for recurrent hepatitis C in liver transplant recipients. (12th May 2015) Authors: Saab, Sammy; Greenberg, Adam; Li, Edwin; Bau, Sherona Ngashea; Durazo, Francisco; El‐Kabany, Mohammed; Han, Steven; Busuttil, Ronald W. Journal: Liver international Issue: Volume 35:Number 11(2015:Nov.) Page Start: 2442 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Treating fibrosing cholestatic hepatitis C with sofosbuvir and ribavirin: a matched analysis. (21st August 2015) Authors: Saab, Sammy; Jimenez, Melissa; Bau, Sherona; Goo, Tyralee; Zhao, Difan; Durazo, Francisco; Han, Steven; El Kabany, Mohammed; Kaldas, Fady; Tong, Myron J.; Busuttil, Ronald W. Journal: Clinical transplantation Issue: Volume 29:Number 9(2015) Page Start: 813 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗